<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 12pt">As
filed with the Securities and Exchange Commission on July&nbsp;28, 2005</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Registration No.&nbsp;333-_____
</DIV>




<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>







<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
</DIV>

<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT
UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of<BR>
incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>41-1978822</B><BR>
(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>10700 Bren Road West<BR>
Minnetonka, Minnesota</B><BR>
(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>55343</B><BR>
(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.<BR>
EMPLOYEE STOCK PURCHASE PLAN</B><BR>
(Full title of the plan)</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Martin J. Emerson<BR>
President and Chief Executive Officer<BR>
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.<BR>
10700 Bren Road West<BR>
Minnetonka, MN 55343<BR>
(952)&nbsp;930-6000</B><BR>
(Name, address and telephone number,<BR>
including area code, of agent for service)</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>CALCULATION OF REGISTRATION FEE</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="39%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD><!-- VRule -->
    <TD width="2%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="4%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="6%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="8%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-bottom: 3px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left"><B>Title of securities to</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Proposed maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Amount of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>


<TD nowrap align="left"><B>be
registered;</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;</TD>

<TD nowrap align="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;registered
(1)&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

<TD nowrap align="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;offering
price per unit (2)&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

<TD nowrap align="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;aggregate
offering price (2)&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD nowrap align="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;registration
fee&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Voting Common Stock
par value<br>$0.01 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">400,000</TD>

<TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$21.85</TD>

<TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$8,740,000</TD>

<TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$1,028.70</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-top: 3px solid #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<DIV style="margin-top: 3pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents the increase in the total number of shares reserved for issuance under the
Employee Stock Purchase Plan. An aggregate of 600,000 shares has been previously registered
under a registration statement on Form S-8 (SEC File No.&nbsp;333-43536), with respect to the 2000
Equity Incentive Plan and the Employee Stock Purchase Plan. In addition, pursuant to Rule
416(c) under the Securities Act of 1933, as amended, this registration statement also includes
an indeterminate number of additional shares as may be issued as a result of anti-dilution
provisions contained in the Employee Stock Purchase Plan.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the amount of the registration fee and
calculated pursuant to Rule 457(c) and (h)&nbsp;under the Securities Act on the basis of the
average between the high and low sales prices of the registrant&#146;s common stock on July&nbsp;21,
2005 on the Nasdaq National Market, as reported by Nasdaq.</TD>
</TR>

</TABLE>
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>








<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">Part II</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;8. Exhibits.</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002"> SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003"> POWER OF ATTORNEY</A></TD></TR>
<TR><TD colspan="9"><A HREF="#004">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="c97039s8exv5w1.htm">Opinion/Consent of Oppenheimer Wolff & Donnelly LLP</A></TD></TR>
<TR><TD colspan="9"><A HREF="c97039s8exv23w1.htm">Consent of Ernst & Young LLP</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>STATEMENT UNDER GENERAL INSTRUCTION E &#151;<BR>
REGISTRATION OF ADDITIONAL SHARES</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Explanatory Note</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The registrant, American Medical Systems Holdings, Inc. (the &#147;Company&#148;), previously filed: a
registration statement on Form S-8 with the Securities and Exchange Commission (SEC File No.
333-43536) in connection with the registration of an aggregate of 8,023,500* shares of the
Company&#146;s voting common stock, $0.01 par value per share, to be issued under the Company&#146;s Employee
Stock Purchase Plan and 2000 Equity Incentive Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to General Instruction E of Form S-8, this registration statement is filed by the Company
solely to register an additional 400,000 shares of voting common stock reserved for issuance under
the Company&#146;s Employee Stock Purchase Plan. This increase was approved by the Company&#146;s Board of
Directors on March&nbsp;29, 2005, subject to approval by the Company&#146;s stockholders. On May&nbsp;5, 2005,
the Company&#146;s stockholders approved the increase in the number of shares reserved for issuance
under the Employee Stock Purchase Plan. Pursuant to General Instruction E, the contents of the
Company&#146;s previously filed registration statement on Form S-8 (SEC File No.&nbsp;333-43536), all annual
and periodic reports that the Company filed, or will file, after the effective date of such prior
registration statement or this registration statement to maintain current information about the
Company, are hereby incorporated by reference into this registration statement pursuant to General
instruction E of Form S-8.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#091;*Note: On March&nbsp;21, 2005, the Company affected a two-for-one stock split in the form of a 100%
stock dividend. All share and per share numbers are hereby deemed to be adjusted accordingly to
reflect this split.&#093;
</DIV>


<!-- link1 "Part II" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Part II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INFORMATION REQUIRED<BR>
IN THE REGISTRATION STATEMENT</B>
</DIV>

<!-- link2 "Item&nbsp;8. Exhibits. " -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8. Exhibits.</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Oppenheimer Wolff &#038; Donnelly LLP (filed herewith electronically).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP (filed herewith electronically).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Oppenheimer Wolff &#038; Donnelly LLP (included in Exhibit&nbsp;5.1).</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included on the signature page to this Registration Statement).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 " SIGNATURES " -->
<DIV align="left"><A NAME="002"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements of filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Minnetonka, State of
Minnesota, on July&nbsp;28, 2005.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="37%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Martin J. Emerson
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Martin J. Emerson&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer<BR>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>



<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="37%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">                                               /s/ Carmen L. Diersen
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Carmen Diersen&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Executive Vice President, Chief Financial Officer<br>and Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif">


<!-- link1 " POWER OF ATTORNEY " -->
<DIV align="left"><A NAME="003"></A></DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Each person whose signature appears below constitutes and appoints Martin J. Emerson and
Carmen Diersen, and each of them, his or her true and lawful attorney-in-fact and agent with full
powers of substitution and resubstitution, for and in his or her name, place and stead, in any and
all capacities, to sign any or all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite or necessary to be done in and about the premises, as fully to all intents and purposes
as he or she might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent or his substitute or substitutes, may lawfully do or cause to be done by
virtue thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed on
July&nbsp;28, 2005 by the following persons in the capacities indicated.
</DIV>
<DIV align="LEFT">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="44%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="51%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Signature</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/      Martin J. Emerson
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Martin J. Emerson</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
President and Chief Executive Officer and Director<BR>(Principal Executive Officer)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Carmen L. Diersen
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Carmen Diersen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Executive Vice President, Chief Financial Officer and Secretary<BR>
(Principal Financial and Accounting Officer)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Douglas W. Kohrs
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Douglas W. Kohrs</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Chairman of the Board</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Richard B. Emmitt
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Richard B. Emmitt</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Christopher H. Porter, Ph.D.
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Christopher H. Porter, Ph. D.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Albert Jay Graf
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Albert Jay Graf</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Elizabeth H. Weatherman
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Elizabeth H. Weatherman</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<TR valign="bottom" style="padding-top: 1em">
    <TD align="left" valign="top">/s/ Thomas Timbie
<DIV style="font-size: 1pt; border-bottom: 1px solid #000000">&nbsp;</DIV>
Thomas Timbie</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">
Director</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "INDEX TO EXHIBITS " -->
<DIV align="left"><A NAME="004"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX TO EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="34%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Item</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Method of Filing</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Oppenheimer Wolff &#038; Donnelly LLP
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith electronically.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed herewith electronically.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Oppenheimer Wolff &#038; Donnelly LLP
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Included in Exhibit&nbsp;5.1.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Included on the signature page to this Registration Statement</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">5
</DIV>
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c97039s8sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 26398}]
{"company-data": {"conformed-name": "AMERICAN MEDICAL SYSTEMS HOLDINGS INC", "cik": "0001114200", "assigned-sic": "3842", "irs-number": "134018241", "state-of-incorporation": "DE", "fiscal-year-end": "1229"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-126993", "film-number": "05981790"}, "business-address": {"street1": "10700 BREN ROAD WEST", "city": "MINNETONKA", "state": "MN", "zip": "55343", "phone": "9529334666"}, "mail-address": {"street1": "10700 BREN ROAD WEST", "city": "MINNETONKA", "state": "MN", "zip": "55343"}}
sv8
Table of Contents
As
filed with the Securities and Exchange Commission on July 28, 2005
Registration No. 333-_____
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
41-1978822
(I.R.S. Employer
Identification No.)
10700 Bren Road West
Minnetonka, Minnesota
(Address of Principal Executive Offices)
55343
(Zip Code)
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plan)
Martin J. Emerson
President and Chief Executive Officer
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
10700 Bren Road West
Minnetonka, MN 55343
(952) 930-6000
(Name, address and telephone number,
including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
Title of securities to
Amount to be
Proposed maximum
Proposed maximum
Amount of
be
registered;
registered
(1)
offering
price per unit (2)
aggregate
offering price (2)
registration
fee
Voting Common Stock
par value
$0.01 per
share
400,000
$21.85
$8,740,000
$1,028.70
(1)
Represents the increase in the total number of shares reserved for issuance under the
Employee Stock Purchase Plan. An aggregate of 600,000 shares has been previously registered
under a registration statement on Form S-8 (SEC File No. 333-43536), with respect to the 2000
Equity Incentive Plan and the Employee Stock Purchase Plan. In addition, pursuant to Rule
416(c) under the Securities Act of 1933, as amended, this registration statement also includes
an indeterminate number of additional shares as may be issued as a result of anti-dilution
provisions contained in the Employee Stock Purchase Plan.
(2)
Estimated solely for the purpose of calculating the amount of the registration fee and
calculated pursuant to Rule 457(c) and (h) under the Securities Act on the basis of the
average between the high and low sales prices of the registrant's common stock on July 21,
2005 on the Nasdaq National Market, as reported by Nasdaq.
TABLE OF CONTENTS
Part II
Item 8. Exhibits.
SIGNATURES
POWER OF ATTORNEY
INDEX TO EXHIBITS
Opinion/Consent of Oppenheimer Wolff & Donnelly LLP
Consent of Ernst & Young LLP
Table of Contents
STATEMENT UNDER GENERAL INSTRUCTION E —
REGISTRATION OF ADDITIONAL SHARES
Explanatory Note
The registrant, American Medical Systems Holdings, Inc. (the "Company"), previously filed: a
registration statement on Form S-8 with the Securities and Exchange Commission (SEC File No.
333-43536) in connection with the registration of an aggregate of 8,023,500* shares of the
Company's voting common stock, $0.01 par value per share, to be issued under the Company's Employee
Stock Purchase Plan and 2000 Equity Incentive Plan.
Pursuant to General Instruction E of Form S-8, this registration statement is filed by the Company
solely to register an additional 400,000 shares of voting common stock reserved for issuance under
the Company's Employee Stock Purchase Plan. This increase was approved by the Company's Board of
Directors on March 29, 2005, subject to approval by the Company's stockholders. On May 5, 2005,
the Company's stockholders approved the increase in the number of shares reserved for issuance
under the Employee Stock Purchase Plan. Pursuant to General Instruction E, the contents of the
Company's previously filed registration statement on Form S-8 (SEC File No. 333-43536), all annual
and periodic reports that the Company filed, or will file, after the effective date of such prior
registration statement or this registration statement to maintain current information about the
Company, are hereby incorporated by reference into this registration statement pursuant to General
instruction E of Form S-8.
[*Note: On March 21, 2005, the Company affected a two-for-one stock split in the form of a 100%
stock dividend. All share and per share numbers are hereby deemed to be adjusted accordingly to
reflect this split.]
Part II
INFORMATION REQUIRED
IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
Exhibit No.
5.1
Opinion of Oppenheimer Wolff & Donnelly LLP (filed herewith electronically).
23.1
Consent of Ernst & Young LLP (filed herewith electronically).
23.4
Consent of Oppenheimer Wolff & Donnelly LLP (included in Exhibit 5.1).
24.1
Power of Attorney (included on the signature page to this Registration Statement).
2
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements of filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Minnetonka, State of
Minnesota, on July 28, 2005.
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
By:
/s/ Martin J. Emerson
Martin J. Emerson
President and Chief Executive Officer
By:
/s/ Carmen L. Diersen
Carmen Diersen
Executive Vice President, Chief Financial Officer
and Secretary
3
Table of Contents
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Martin J. Emerson and
Carmen Diersen, and each of them, his or her true and lawful attorney-in-fact and agent with full
powers of substitution and resubstitution, for and in his or her name, place and stead, in any and
all capacities, to sign any or all amendments (including post-effective amendments) to this
Registration Statement, and to file the same, with all exhibits thereto, and other documents in
connection therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite or necessary to be done in and about the premises, as fully to all intents and purposes
as he or she might or could do in person, hereby ratifying and confirming all that said
attorney-in-fact and agent or his substitute or substitutes, may lawfully do or cause to be done by
virtue thereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed on
July 28, 2005 by the following persons in the capacities indicated.
Signature
Title
/s/      Martin J. Emerson
Martin J. Emerson
President and Chief Executive Officer and Director
(Principal Executive Officer)
/s/ Carmen L. Diersen
Carmen Diersen
Executive Vice President, Chief Financial Officer and Secretary
(Principal Financial and Accounting Officer)
/s/ Douglas W. Kohrs
Douglas W. Kohrs
Chairman of the Board
/s/ Richard B. Emmitt
Richard B. Emmitt
Director
/s/ Christopher H. Porter, Ph.D.
Christopher H. Porter, Ph. D.
Director
/s/ Albert Jay Graf
Albert Jay Graf
Director
/s/ Elizabeth H. Weatherman
Elizabeth H. Weatherman
Director
/s/ Thomas Timbie
Thomas Timbie
Director
4
Table of Contents
INDEX TO EXHIBITS
No.
Item
Method of Filing
5.1
Opinion of Oppenheimer Wolff & Donnelly LLP
Filed herewith electronically.
23.1
Consent of Ernst & Young LLP.
Filed herewith electronically.
23.4
Consent of Oppenheimer Wolff & Donnelly LLP
Included in Exhibit 5.1.
24.1
Power of Attorney.
Included on the signature page to this Registration Statement
5